| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,015 |
4,348 |
$215K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,182 |
1,087 |
$67K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
640 |
635 |
$37K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
856 |
759 |
$27K |
| T1015 |
Clinic visit/encounter, all-inclusive |
144 |
110 |
$23K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,039 |
988 |
$8K |
| 99051 |
|
147 |
143 |
$4K |
| 87428 |
|
59 |
58 |
$3K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
52 |
52 |
$3K |
| 99442 |
|
77 |
77 |
$2K |
| 0012A |
|
46 |
46 |
$2K |
| 0011A |
|
51 |
51 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
30 |
28 |
$676.58 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13 |
13 |
$392.66 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
30 |
15 |
$318.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
36 |
36 |
$221.40 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
13 |
$131.23 |
| 96127 |
|
35 |
35 |
$81.95 |
| 81002 |
|
14 |
13 |
$27.96 |
| 82962 |
|
12 |
12 |
$18.11 |
| 90686 |
|
79 |
66 |
$3.75 |
| 90674 |
|
12 |
12 |
$0.60 |